Zusammenfassung
Die erhöhte Krebsgefährdung von Patienten mit chronisch-entzündlichen Darmerkrankungen ist allgemein bekannt. Sie hat Eingang in die Lehrbücher gefunden und ist im Gegenstandskatalog des Instituts für Medizinische und Pharmazeutische Prüfungsfragen aufgeführt. Die pauschale Feststellung ist in dieser Form jedoch nicht akzeptabel und bedarf verschiedener Differenzierungen. Diese betreffen:
-
1)
die Ausdehnung der Colitis,
-
2)
die Dauer der Erkrankung,
-
3)
die Schwere der Erkrankung,
-
4)
die Unterscheidung in Colitis ulcerosa und M. Crohn,
-
5)
das Auftreten von Dysplasien in der Schleimhaut.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Blackstone M, Riddell RH, Rogers B, Levin B (1981) Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long standing ulcerative colitis:an indication for colectomy. Gastroenterology 80:306–374
Boland CR, Lance P, Levin B, Riddell RH, Kim YS (1984) Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis:Early results of a prospective study. Gut 25:1364–1371
Butt JH, Lennard-Jones JE, Ritchie JK (1980) A practical approach to the cancer risk in inflammatory bowel disease. Med Clin N Am 64:1203–1220
Butt JH, Koniski F, Morson BC, Lennard-Jones JE, Ritchie J (1983) Macroscopic lesions in dysplasia complicating ulcerative colitis. Dig Dis Sci 28:18–26
Collins RH, Feldman M, Fordtran JS (1987) Colon cancer, dysplasia and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 316:1654–1658
De Dombal F, Watts J, Watkinson G, Goligher J (1966) Lokal complications of ulcerative colitis:stricture, pseudopolyposis and carcinoma of colon and rectum. Br Med J 1:1442–1447
Devroede GI, Taylor WF, Sauer WG, Jackman RI, Stickler GB (1971) Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 285:17–21
Dobbins WO (1984) Dysplasia and malignancy in inflammatory bowel disease. Am Rev Med 35:33–48
Gilat T, Freman A, Groosman A et al. (1988) Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology 94:870–877
Greenstein AJ, Sachar DB, Smith H et al. (1979) Cancer in universal and left-sided ulcerative colitis:factors determining risk. Gastroenterology 77:290–294
Gyde SN, Prior P, Allan RN et al. (1988) Colorectal cancer in ulcerative colitis:a cohort study of primary referrals from three centres. Gut 29:206–217
Hammarberg C, Rubio C, Slezak P, Tribukait B, Öhman U (1984) Flow-cytometric DNA analysis as a mean for early detection of malignancy in patients with ulcerative colitis. Gut 25:905–908
Johnson W, McDermott F, Hughas E, Pihl E, Mike E, Price EA (1983) Carcinoma of the colon and rectum in inflammatory bowel disease of the intestine. Surg Gyn Obstet 156:193–197
Katzka I, Brody RS, Morris E, Katz S (1983) Assessment of colorectal cancer risk in patients with ulcerative colitis:experience from a private practice. Gastroenterology 85:22–29
Lennard-Jones JE (1985) Cancer risk in ulcerative colitis:surveillance of surgery. Br J Surg 72 [Suppl]:84–86
Lennard-Jones JE, Ritchie JK, Marson BC, Williams CB (1983) Cancer surveillance in ulcerative colitis. Lancet 2:149–152
Morson BC, Pang LSC (1967) Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 8:423–434
Petras RE, Mir-Madylessi SH, Farmer RG (1987) Crohn’s disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 93:1307–1314
Prior P, Gyde SN, Macartney JC, Thomson H, Waterhouse JAH, Allan RN (1982) Cancer morbidity in ulcerative colitis. Gut 23:490–497
Riddell RH, Goldman H, Ransohoff DF, Appelman H (1983) Dysplasia in inflammatory bowel disease:standardised classification with provisional clinical applications. Hum Pathol 14:931–968
Riddell RH, Schmidt H, Levin B (1984) Cancer in Barrett’s esophagus and inflammatory bowel disease — what’s new. In:Levin B, Riddell RH (eds) Frontiers in gastroenterological cancer. Elsevier, New York, pp 307 — 319
Rosenstock E, Farmer RG, Petras R, Givak MV, Rankin GB, Sulliman BH (1985) Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 89:1342–1346
Waye JD (1986) Screening for cancer in ulcerative colitis. Front Gastroent Res 10:243–256
Whelan G (1980) Cancer risk in ulcerative colitis:why are results in the literature so varied? Clin Gastroenterol 9:469–476
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ewe, K. (1989). Chronisch-entzündliche Darmerkrankungen und Dickdarmkrebs. In: Matek, W. (eds) Früherkennung und Nachsorge des Dickdarmkrebses. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74322-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-74322-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50596-9
Online ISBN: 978-3-642-74322-1
eBook Packages: Springer Book Archive